Korean Ginseng Industry and Herbal Medicine

Korean ginseng (인삼, insam), particularly the prized cultivar Panax ginseng C.A. Meyer, represents one of South Korea’s most distinctive and enduring exports, blending ancient medicinal traditions with modern commercial cultivation, pharmaceutical development, and global commerce. South Korea is the world’s leading producer and exporter of Panax ginseng specifically (distinct from closely related species cultivated elsewhere), and the ginseng industry generates approximately USD 1.5–2 billion annually in domestic market revenue, with exports reaching around USD 300–400 million annually. The industry exemplifies Korea’s strategy of leveraging traditional cultural and medicinal knowledge for modern commercial and pharmaceutical development—a model that has influenced Korea’s broader pharmaceutical and biotech sector.

Historical Origins and Traditional Use

Ginseng has been central to Korean medicine and culture for over two millennia. The earliest written references in Chinese texts (the Shennong Bencao Jing, approximately 200 CE) mention Korean ginseng as a superior medicinal root. Korean historical texts including the Samguk Sagi (compiled 1145 CE) and the Goryeo-sa confirm ginseng’s importance during the Three Kingdoms and Goryeo periods. Its use became systematized within Korean traditional medicine (hanbang or Oriental medicine) and East Asian medical systems broadly.

In traditional Korean medicine, ginseng was prized as a tonic and restorative herb. The Dongui Bogam (동의보감, “Principles and Practice of Eastern Medicine”), compiled by royal physician Heo Jun and published in 1613, is the foundational text of Korean traditional medicine and devotes extensive attention to ginseng (insam). The Dongui Bogam classifies ginseng as a superior tonic capable of strengthening the body’s vital energy (gi or qi), improving digestion, enhancing longevity, and addressing conditions related to exhaustion and weakness. The work is recognized by UNESCO as a Memory of the World document.

Wild Korean ginseng (sansam, 산삼) became increasingly rare and expensive as demand grew across East Asia, spurring the development of cultivated ginseng. By the 15th and 16th centuries, cultivated ginseng gardens were established in Korea, and ginseng cultivation became a significant agricultural and trade activity. The Joseon dynasty (1392–1897) maintained strict state monopoly control over ginseng exports, recognizing its strategic economic value. Ginseng tribute was central to Korea’s tributary relationship with China, and Korean ginseng was among the most valuable commodities circulating in the East Asian trade network.

A transformative development came in the early 20th century when the Japanese colonial government established standardized red ginseng processing facilities in Gaeseong (now in North Korea) in 1908 and created the Korea Ginseng Corporation (Korea Tobacco and Ginseng Corporation, or KT&G, predecessor), establishing a state-managed industry that persisted through modern times.

Modern Cultivation and Production

Contemporary Korean ginseng cultivation operates at massive industrial scale. South Korea is the world’s second-largest ginseng producer by volume (after China, which cultivates larger quantities of related species and Chinese varieties) and the leading producer of Panax ginseng meeting premium quality standards. Total Korean ginseng production reached approximately 24,000–28,000 metric tons of fresh root annually in recent years.

The primary cultivation region is Geumsan County (금산군) in South Chungcheong Province (충청남도), which accounts for over 70–80% of Korea’s annual ginseng production and exports. Geumsan hosts the famous Geumsan Ginseng Market, one of the world’s largest ginseng wholesale markets, with approximately 800 merchants and dealers operating year-round. The market hosts an annual Geumsan World Ginseng & Herb Festival (금산인삼축제) attracting hundreds of thousands of visitors annually, reflecting ginseng’s dual role as commercial commodity and cultural touchstone. Geumsan lies in the central region adjoining Daejeon; see also the Tourism Industry.

Other significant cultivation regions include Gangwon Province (강원도), Gyeonggi Province (경기도, particularly Paju and Ganghwa Island), and parts of North Jeolla Province.

Agricultural Methods and Production Cycle

Ginseng cultivation is labor-intensive and ecologically demanding. The plant (Panax ginseng) is a slow-growing perennial herb native to the montane forests of northeastern Asia. It thrives in temperate climates with well-drained, slightly acidic loam soils, and requires partial shade—traditionally 50–70% light filtration.

Korean ginseng farmers construct shade structures (haega, 해가림) using wooden or metal frames and shade cloth that simulate forest-like growing conditions. These structures represent significant capital expenditure; a single hectare of shade infrastructure can cost 10–20 million won or more to establish.

The cultivation cycle is exceptionally lengthy: commercial Korean red ginseng requires 4–6 years from planting to harvest. Four-year-old ginseng (sanyeonggeun) is standard for many products, while six-year-old ginseng (yuknyeonggeun) commands significantly higher prices and is used in premium formulations. This extended cycle creates supply-side inertia and price stability but requires substantial capital investment and patience.

A critical agricultural constraint is that ginseng cannot be replanted on the same land for 10–15 years after harvest, due to “ginseng sickness”—a complex of soil pathogens and microbiological changes caused by ginseng cultivation. This requirement effectively means that Korea’s total ginseng-producing land must cycle through fallow periods, limiting total productive capacity.

Modern cultivation incorporates soil science, mechanized field preparation, pesticide and fungicide management programs, and quality-control sampling at harvest. Ongoing research at the Korea Ginseng Research Institute (한국인삼연구소) in Geumsan and at agricultural universities addresses improving yield, disease resistance, and ginsenoside profiles.

Processing and Product Forms

Harvested fresh root (sunsam) undergoes processing into various commercial forms with distinct chemical profiles and commercial uses:

• Red Ginseng (홍삼, honginsam) — The most commercially important processed form. Fresh ginseng is steamed at approximately 90–100°C for 2–3 hours, then dried over multiple cycles, resulting in a translucent reddish-brown root. Steaming initiates the Maillard reaction and enzymatic conversions, producing unique ginsenosides (including Rg2, Rg3, Rh1, and Rh2) not found in substantial quantities in unprocessed root. Red ginseng commands significant price premiums over white ginseng.
• White Ginseng (백삼, baekinsam) — Sun-dried ginseng without the steaming step, retaining a pale ivory color. Peeled white ginseng (jiksamtaebaek) and unpeeled varieties are marketed domestically and to overseas Korean communities.
• Extracts and Concentrates (농축액) — Ginseng root is water-extracted under heat and reduced to thick concentrates (typically 35 Brix or higher) used in beverages, pharmaceutical tonics, and supplement capsules. The classic “red ginseng concentrate in a glass bottle” is among Korea’s most recognized health product formats.
• Ginseng-based Consumer Products — Cosmetics, functional beverages (e.g., KGC’s “Cheong Kwan Jang” branded drinks), energy drinks, confectioneries, and pharmaceutical formulations incorporating ginseng as an active ingredient.

Export and Global Commerce

Korean ginseng reaches markets in over 60 countries. Major export destinations include China, Hong Kong, Taiwan, the United States, Japan, Canada, and Southeast Asian nations with large Korean or Chinese-origin communities. In 2022, Korea’s total ginseng-related exports were valued at approximately USD 250–350 million.

South Korean ginseng commands significant price premiums over Chinese-grown ginseng in global markets—often 2–5 times higher per unit—marketed as superior quality based on cultivation region, climate, soil characteristics, and rigorous quality control. The claim of Korean peninsula terroir (particularly the specific combination of temperate continental climate with mineral-rich soils) is central to Korean ginseng branding internationally.

Korea Ginseng Corporation (KGC, 한국인삼공사) — Founded in 1899 (in ancestor form under the Joseon government), nationalized through the Japanese colonial period, and eventually privatized in 2002 when the state monopoly on red ginseng ended. KGC operates through the Cheong Kwan Jang (정관장) brand, which is the world’s most widely distributed Korean red ginseng brand and generates annual revenues exceeding 1 trillion Korean won (approximately USD 700–800 million in recent years). KGC maintains flagship stores in Seoul (including at Incheon International Airport), major Korean cities, and over 40 international markets. The brand occupies premium retail positions in North American Korean supermarkets, Chinatown pharmacies, and online health retail platforms.

Private exporters and cooperative marketing organizations also operate significantly, including the Geumsan Ginseng Cooperative and numerous private label manufacturers targeting specific regional markets.

Distribution channels include wholesale ginseng markets (particularly in Geumsan, Hong Kong, and Chinese mainland cities), retail distribution through health and wellness channels in Western markets, e-commerce platforms, and integration into functional food and pharmaceutical products.

The domestic Korean market itself is substantial: surveys indicate roughly 25–35% of South Korean adults consume ginseng-based products regularly, with consumption peaks during gift-giving seasons (Lunar New Year and Chuseok, see Chuseok). Ginseng gift sets remain among the most popular premium gift items in Korean culture.

Scientific Research and Validation

A significant aspect of the Korean ginseng industry is the systematic scientific research program validating traditional medicinal uses and characterizing bioactive compounds. South Korea has invested hundreds of billions of won in ginseng research since the 1970s, with dedicated institutions including:

• Korea Ginseng Research Institute (KGRI) in Geumsan
• Korea Institute of Oriental Medicine (KIOM, 한국한의학연구원) in Daejeon
• Dedicated ginseng research programs at major universities including Korea University, Kyung Hee University, and Chungnam National University

Research has identified approximately 40–50 distinct ginsenosides (triterpenoid saponins) as the primary bioactive constituents of Panax ginseng, classified as protopanaxadiol (PPD) and protopanaxatriol (PPT) types. Major ginsenosides including Rb1, Rb2, Rc, Rd (PPD types), Re, Rf, Rg1 (PPT types), and the red-ginseng-specific Rg3, Rh1, and Rh2 have been studied for pharmacological effects.

Clinical and preclinical studies have examined ginseng effects on:

• Immune modulation — Enhancement of natural killer cell activity and cytokine production
• Cognitive function — Improvement in memory, reaction time, and attention; potential applications in age-related cognitive decline
• Physical endurance — Reduction in exercise-induced fatigue and enhancement of VO2 max in controlled trials
• Glycemic regulation — Improvement in insulin sensitivity and post-prandial glucose levels, particularly in type 2 diabetes
• Anti-tumor activity — Preclinical evidence for ginsenoside inhibition of tumor cell proliferation and metastasis
• Cardiovascular effects — Vasodilation, platelet aggregation inhibition, and lipid profile improvement

Scientific validation has supported ginseng’s expansion into pharmaceutical development and dietary supplements marketed with health claims in regulated markets, particularly in the European Union and United States where ginseng is classified as a botanical supplement. The Korean pharmaceutical and biotech industry has leveraged ginseng research to develop standardized ginseng-based pharmaceuticals meeting regulatory evidence standards.

Herbal Medicine and Traditional Korean Medicine (Hanbang)

Beyond commercial ginseng, the broader herbal medicine sector in South Korea encompasses the formulation and practice of traditional Korean medicine (hanbang, 한방), a systematized medical tradition formally recognized by the Korean government and regulated under the Medical Service Act. Korea maintains a dual-track licensed medical system in which biomedical doctors (uisa, 의사) and Oriental medicine doctors (hanbang-uisa, 한방의사) hold separate licenses and practice in separate (though sometimes co-located) facilities.

As of the early 2020s, Korea had approximately 25,000–28,000 licensed Oriental medicine practitioners and roughly 15,000 Oriental medicine clinics (hanbang uiwon). Oriental medicine (hanbang) services are partially covered by Korea’s National Health Insurance system, representing a significant policy commitment to traditional medicine alongside biomedicine. See Healthcare System in South Korea for details on integration of traditional and biomedical care.

The Korea Institute of Oriental Medicine (KIOM) — A government research institute established in 1994, headquartered in Daejeon, conducts clinical and basic research on traditional Korean medical practices, herbal formulations, and acupuncture. KIOM participates in international WHO programs on traditional medicine standardization.

Beyond ginseng, Korean herbal medicine employs hundreds of additional medicinal substances (약재, yakjae) including:

• Hwanggi (astragalus root, 황기) — used as an immune tonic
• Dang-gui (angelica root, 당귀) — used in gynecological formulations
• Acanthopanax bark (ogapi, 오가피) — used for musculoskeletal conditions
• Rehmannia root (sukhwang, 숙황) — used as a kidney tonic in complex formulations
• Licorice root (gamcho, 감초) — a harmonizing herb used in most complex formulas

The herbal medicine pharmaceutical sector includes companies producing standardized herbal extract granules, pills, and tinctures meeting Korean Good Manufacturing Practice (GMP) standards. Companies like Kwang Dong Pharmaceutical, Hanmi Pharmaceutical (also a biomedical company), and Jeil Healthcare produce herbal pharmaceutical products distributed through Oriental medicine clinics and pharmacies.

Cultural and Tourist Significance

Ginseng occupies a uniquely prominent place in Korean cultural life beyond its economic function. The Geumsan Ginseng Market and annual festival represent a major cultural attraction drawing domestic and international tourists. Ginseng is integrated into Korean cuisine through preparations like samgyetang (ginseng chicken soup, 삼계탕), consumed especially on the three hottest days of summer (sambok, 삼복) as a hot-weather tonic in accordance with traditional dietary medicine.

Ginseng-themed tourism, farm visits, and processing workshops in Geumsan and other cultivation regions have developed into specialized tourism experiences, contributing to rural tourism and agricultural heritage preservation.

Challenges and Contemporary Issues

The Korean ginseng industry faces several significant challenges:

• International Competition — China’s vastly larger ginseng production at lower costs, combined with competition from North American ginseng varieties (Panax quinquefolius, or American ginseng, grown in Wisconsin and Ontario), pressures Korean producers to maintain premium positioning through quality differentiation and branding.
• North Korean Competition — Historically, Gaeseong (Kaesong) in North Korea was the center of Korean ginseng production, and North Korean red ginseng has been marketed internationally at competitive prices. The division of the peninsula severed this industry, but North Korean ginseng exports (routed through China) compete in some markets.
• Regulatory Variability — Varying international regulations on health claims for ginseng complicate export marketing. The United States FDA classifies ginseng as a dietary supplement (not a drug), limiting permitted health claims. EU botanical regulations require evidence meeting specific standards. Japan has detailed Kampo (traditional medicine) drug classifications that apply to imports.
• Agricultural Labor and Succession — Korean ginseng cultivation faces labor shortages and aging farmer demographics as younger generations migrate to urban centers. Average Korean farmer age exceeds 65; succession challenges threaten small-scale ginseng farming.
• Sustainability and Land Management — The 10–15 year land rotation requirement limits productive capacity and raises costs. Climate change’s effects on Korean temperature and precipitation patterns present unknown risks to optimal cultivation conditions.
• Authenticity and Counterfeiting — Premium Korean ginseng products face counterfeiting and adulteration risks in international markets, where cheaper Chinese or artificial substitutes may be mislabeled. KGC and industry groups have lobbied for stronger geographic indication (GI) protections internationally.

Economic Significance in Context

The ginseng industry contributes to South Korea’s agricultural export economy and pharmaceutical sector. It represents a successful model of valorizing traditional knowledge through scientific research, quality control, branding, and global market development—a template also visible in Korea’s K-beauty sector and biotechnology industry. The state’s historical role in ginseng—from Joseon royal monopoly to Japanese colonial management to post-war government enterprise to privatization—illustrates the evolution of Korean industrial policy from state-led development toward market-oriented structures.

Related

• Pharmaceutical and Biotech Industry — the modern life-sciences sector that ginseng research feeds into
• Healthcare System in South Korea — the licensed Oriental-medicine (hanbang) system within national healthcare
• K-beauty and Cosmetics Industry — a parallel model of valorizing traditional knowledge for global export
• Korean Cuisine and Food Culture — samgyetang and ginseng’s place in Korean foodways